Ten-year Risk of Atherosclerotic Cardiovascular Disease Predicts Long-Term Mortality in Lipid-Lowering Therapy

被引：0
|
作者：
Ma, Zhiyuan
Moran, Lynn N.
Shirani, Jamshid
机构：
来源：
CIRCULATION | 2023年 / 148卷
关键词：
Cholesterol-lowering drugs; Mortality; Risk Factors; Cardiovascular disease prevention;
D O I：
10.1161/circ.148.suppl_1.11813
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A11813
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Ten-year atherosclerotic cardiovascular disease risk prediction for postmenopausal women: Impacts of isolated postchallenge hyperglycemia
    Wu, Tsung-Hui
    Lin, Yi-Chun
    Hwu, Chii-Min
    MEDICINE, 2022, 101 (36) : E30352
  • [42] Unused potential of lipid-lowering therapy in very high-risk patients with atherosclerotic cardiovascular disease. A retrospective data analysis
    Pohl, Sarah B.
    Engelbertz, Christiane
    Reinecke, Holger
    Malyar, Nasser M.
    Meyborg, Matthias
    Brix, Tobias J.
    Varghese, Julian
    Gebauer, Katrin
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2024, 34 (07) : 1670 - 1680
  • [43] Lipid-lowering Therapy in Patients With High Cardiovascular Risk: Dose or Combination?
    Roever, Leonardo
    Biondi-Zoccai, Giuseppe
    Rao, Sunil V.
    CLINICAL THERAPEUTICS, 2017, 39 (03) : 659 - 660
  • [44] How to overcome barriers to the implementation of prevention and treatment strategies for atherosclerotic cardiovascular disease through lipid-lowering therapy
    Arca, Marcello
    Averna, Maurizio
    Borghi, Claudio
    Lettino, Maddalena
    Filardi, Pasquale Perrone
    Alberti, Antonia
    Bilato, Claudio
    Calabro, Paolo
    Carubbi, Francesca
    Ciccone, Marco Matteo
    Cipollone, Francesco
    Citroni, Nadia
    De Luca, Leonardo
    Giaccari, Andrea
    Iannuzzo, Gabriella
    Maloberti, Alessandro
    Marcucci, Rossella
    Spinazzola, Pasquale Pignatelli
    Pirro, Matteo
    Pisciotta, Livia
    Sarullo, Filippo
    Sciacqua, Angela
    Suppressa, Patrizia
    Varbella, Ferdinando
    Werba, Jose Pablo
    Zambon, Alberto
    GIORNALE ITALIANO DI CARDIOLOGIA, 2023, 24 (10) : 770 - 780
  • [45] Lifestyle Interventions Reduce Ten-Year Risk of Atherosclerotic Cardiovascular Disease as Predicted by the Pooled Cohort Equations
    Hinderliter, Alan
    Smith, Patrick
    Sherwood, Andrew
    Blumenthal, James
    CIRCULATION, 2014, 130
  • [46] Individualized lipid-lowering therapy to further reduce residual cardiovascular risk
    Weingaertner, Oliver
    Luetjohann, Dieter
    Ploesch, Torsten
    Elsaesser, Albrecht
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2017, 169 : 198 - 201
  • [47] Lipid-lowering therapy for patients with or at risk of coronary artery disease
    Kjekshus, J
    Pedersen, TR
    Tobert, JA
    CURRENT OPINION IN CARDIOLOGY, 1996, 11 (04) : 418 - 427
  • [48] Absolute risk of cardiovascular disease events, and blood pressure- and lipid-lowering therapy in Australia
    Banks, Emily
    Crouch, Simon R.
    Korda, Rosemary J.
    Stavreski, Bill
    Page, Karen
    Thurber, Katherine A.
    Grenfell, Robert
    MEDICAL JOURNAL OF AUSTRALIA, 2016, 204 (08) : 320.e1 - 320.e8
  • [49] Absolute risk of cardiovascular disease events and blood pressure- and lipid-lowering therapy in Australia
    Banks, Emily
    Korda, Rosemary J.
    Stavreski, Bill
    MEDICAL JOURNAL OF AUSTRALIA, 2017, 206 (01) : 51 - +
  • [50] Ten-year fatal risk for cardiovascular disease (CVD) in psoriasis
    Schopf, R. E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (08) : S39 - S39
12345